Sana Biotechnology Inc (NASDAQ: SANA) kicked off on Tuesday, up 11.51% from the previous trading day, before settling in for the closing price of $2.52. Over the past 52 weeks, SANA has traded in a range of $1.26-$7.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 34.68%. With a float of $125.44 million, this company’s outstanding shares have now reached $225.46 million.
The firm has a total of 194 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sana Biotechnology Inc (SANA) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Sana Biotechnology Inc is 44.39%, while institutional ownership is 51.55%. The most recent insider transaction that took place on Feb 18 ’25, was worth 237,000. Before that another transaction happened on Jan 16 ’25, when Company’s Officer proposed sale 75,000 for $3.86, making the entire transaction worth $289,500.
Sana Biotechnology Inc (SANA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 34.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.07% during the next five years compared to -10.60% drop over the previous five years of trading.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
Take a look at Sana Biotechnology Inc’s (SANA) current performance indicators. Last quarter, stock had a quick ratio of 3.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.88, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Analysing the last 5-days average volume posted by the [Sana Biotechnology Inc, SANA], we can find that recorded value of 3.33 million was lower than the volume posted last year of 5.8 million. As of the previous 9 days, the stock’s Stochastic %D was 49.59%. Additionally, its Average True Range was 0.24.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 64.85%, which indicates a significant decrease from 72.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.74% in the past 14 days, which was lower than the 112.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.99, while its 200-day Moving Average is $2.84. Now, the first resistance to watch is $2.93. This is followed by the second major resistance level at $3.05. The third major resistance level sits at $3.25. If the price goes on to break the first support level at $2.61, it is likely to go to the next support level at $2.41. Should the price break the second support level, the third support level stands at $2.29.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
The company with the Market Capitalisation of 633.81 million has total of 225,477K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -266,760 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -49,390 K.
